Post-Graduate Year 2 (PGY2): Oncology Pharmacy
Post-Graduate Year 2 (PGY2): Oncology Pharmacy
Residency Details
Our post-graduate year 2 (PGY2) oncology pharmacy residency program helps residents develop expertise and competency in providing pharmaceutical care services to cancer patients in both inpatient and ambulatory settings. Required rotations include adult and pediatric oncology, bone marrow transplant, oncology specialty pharmacy, infusion and hospice/palliative care. Longitudinal experiences include administration, research, tumor board attendance, participation in an oncology pharmacy and therapeutics (P&T) committee. Residents will also have opportunities to teach through direct precepting of PGY1 residents and students as well as opportunities to lecture in the oncology module and participate in the oncology elective at Idaho State University.
This 12 month program offers an approximately $61,000 stipend, benefits, and paid time off.
Residency Start Date: First or second Monday in July (depending on when the holiday falls)
Residency Program Details
- Orientation - 2 weeks
- Medical oncology/infusion - 6 weeks
- Oncology specialty pharmacy - 6 weeks
- Inpatient oncology - 5 weeks
- Blood and marrow transplant - 5 weeks
- Pediatric oncology - 5 weeks
- Hospice/palliative care - 4 weeks
- Precepting - 4 weeks
Accreditation
The PGY2 Oncology Pharmacy Residency conducted by St. Luke's Health System, Boise, ID is accredited by ASHP.
More Information
Living and Working in Boise
Boise is ranked one of the best places to live due to cost of living, family life, employment, and work/life balance.
The Pharmacy Residency Experience
When surveyed, our past and current pharmacy residents shared that they appreciate the culture, environment and career.
